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Abstract
Background: Several novel susceptibility loci for type 2 diabetes have been identified through genome-wide association
studies (GWAS) for type 2 diabetes or quantitative traits related to glucose metabolism in European populations. To
investigate the association of the 13 new European GWAS-derived susceptibility loci with type 2 diabetes in the Japanese
population, we conducted a replication study using 3 independent Japanese case-control studies.
Methodology/Principal Findings: We examined the association of single nucleotide polymorphisms (SNPs) within 13 loci
(MTNR1B, GCK, IRS1, PROX1, BCL11A, ZBED3, KLF14, TP53INP1, KCNQ1, CENTD2, HMGA2, ZFAND6 and PRC1) with type 2
diabetes using 4,964 participants (2,839 cases and 2,125 controls) from 3 independent Japanese samples. The association of
each SNP with type 2 diabetes was analyzed by logistic regression analysis. Further, we performed combined meta-analyses
for the 3 studies and previously performed Japanese GWAS data (4,470 cases vs. 3,071 controls). The meta-analysis revealed
that rs2943641 in the IRS1 locus was significantly associated with type 2 diabetes, (P=0.0034, OR=1.15 95% confidence
interval; 1.05–1.26) and 3 SNPs, rs10930963 in the MTNR1B locus, rs972283 in the KLF14 locus, and rs231362 in the KCNQ1
locus, had nominal association with type 2 diabetes in the present Japanese samples (P,0.05).
Conclusions: These results indicate that IRS1 locus may be common locus for type 2 diabetes across different ethnicities.
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Introduction
Type 2 diabetes is a chronic metabolic disorder characterized
by hyperglycemia, variable degrees of insulin resistance, and
impaired insulin secretion. The total number of individuals with
diabetes mellitus is estimated to be nearly 300 million worldwide,
and its prevalence continues to increase in many countries,
including Japan. Although the precise mechanisms underlying the
development and progression of type 2 diabetes have not been
elucidated, it is considered that genetic factors play an important
role in the pathogenesis of the disease [1]
Currently, approximately 40 susceptibility loci for type 2
diabetes, mostly discovered through genome-wide association
studies (GWAS), have been confirmed in populations of European
descent (the Wellcome Trust Case Control Consortium/United
Kingdom Type 2 Diabetes Genetics consortium [WTCCC/
UKT2D], Diabetes Genetics Initiative [DGI], Finland-US
Investigation of NIDDM genetics [FUSION], GWAS performed
by deCODE genetics, Diabetes Gene Discovery Group [DGDG]
and DIAbetes Genetics Replication and Meta-analysis [DIA-
GRAM]) [2–6]. Three Japanese GWAS including ours, have
identified the association of the potassium voltage-gated channel
KQT-like subfamily member 1 (KCNQ1) locus, ubiquitin-conju-
gating enzyme E2E 2 (UBE2E2) locus and C2 calcium-dependent
domain containing 4A (C2CD4A)-C2CD4B locus with type 2
diabetes [7–9].
Because many of these loci have also been shown to be
associated with type 2 diabetes in other ethnic populations,
including Japanese, these loci may be considered convincing
susceptibility loci for type 2 diabetes across different ethnicities
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26911[10–12]. Recently, a locus near insulin receptor substrate 1 (IRS1)
was identified by GWAS on French patients [13]. Several new loci
for type 2 diabetes have been additionally identified through
GWAS for quantitative traits related to glucose metabolism, such
as fasting plasma glucose (FPG) and 2-hour glucose levels (Meta-
Analyses of Glucose and Insulin-related traits Consortium
[MAGIC]) [14–18]. In addition, 12 novel loci for type 2 diabetes
have been identified in an expanded meta-analysis of the existing
GWAS data (DIAGRAM+) [19].
In this study, we aim to evaluate the contribution of these new
susceptibility loci identified in European GWAS to conferring
susceptibility to type 2 diabetes in the Japanese.
Methods
Participants and DNA preparation
We selected 4,964 individuals, 2,839 cases and 2,125 controls,
from 3 independent Japanese samples.
RIKEN case-control study (1
st study): DNA samples were
obtained from peripheral blood samples of type 2 diabetes patients
recruited from the outpatient clinics of the Shiga University of
Medical Science and the Kawasaki Medical School (Case 1;
n=1,630, 978 men and 652 women), We also examined 716
controls who were enrolled in an annual health check conducted
either at the Juntendo University or the Keio University (Control
1; n=716, 465 men and 251 women).
Toyama University study (2
nd study): We selected 724 individuals
with type 2 diabetes from the outpatient clinic of the Toyama
UniversityHospital(Case2;n=724,451 menand273women).We
also examined 763 controls with HbA1c,6.0%, age$50, no family
history of diabetes mellitus for the first and second degree relatives
(Control 2; n=763, 359 men and 404 women).
St. Marianna University study (3
rd study): We recruited 485
individuals with type 2 diabetes from the outpatient clinic of the St.
Marianna University School of Medicine (Case 3; n=485, 288
men and 197 women). We also examined 646 controls, who were
enrolled in an annual health check conducted at the St. Marianna
University School of Medicine (Control 3; n=646, 188 men and
458 women)
The clinical characteristics of the participants are summarized
in Table 1. Diabetes was diagnosed according to the World Health
Organization (WHO) criteria [20]. Type 2 diabetes is clinically
defined as a disease with gradual adult onset. Subjects who tested
positive for anti-glutamic acid decarboxylase (GAD) antibodies
and those diagnosed to have mitochondrial disease (mitochondrial
myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
[MELAS]) or maturity onset diabetes of young (MODY) were not
included in the case patient groups. Written informed consents
were obtained from all participants. DNA was extracted using the
standard phenol-chloroform procedure. The protocol was ap-
proved by the ethics committees of the RIKEN Yokohama
Institute, Shiga University of Medical Science, Keio University,
Toyama University, University of Tokyo, Juntendo University and
St. Marianna University School of Medicine, or by Institutional
Review Board of Kawasaki Medical School.
Single nucleotide polymorphisms genotyping
We first selected 9 single nucleotide polymorphisms (SNPs) from
previous reports, rs2943641 within the locus near the IRS1 [13],
and 8 SNPs from the loci identified through GWAS for
quantitative traits related to glucose metabolism (rs10830963
[14,15] and rs1387153 [16] in the melatonin receptor 1B
[MTNR1B] locus, rs780094 in the glucokinase regulator [GCKR]
locus, rs730497 in the glucokinase [GCK] locus, rs11708067 and
rs2877716 in the adenylate cyclase 5 [ADCY5] locus, rs2191349 in
the diacylglycerol kinase, beta [DGKB]- transmembrane protein
195 [TMEM195] locus, and rs340874 in the prospero homeobox 1
[PROX1] locus [17,18]). We also examined 11 autosomal SNPs
from 11 novel loci for type 2 diabetes recently identified in an
expanded meta-analysis of existing GWAS data (rs243021 in the
B-cell CLL/lymphoma 11A [BCL11A] locus, rs4457053 in the
zinc finger, BED-type containing 3 [ZBED3] locus, rs972283 in
the Kruppel-like factor 14 [KLF14] locus, rs896854 in the tumor
protein p53 inducible nuclear protein 1 [TP53INP1] locus,
rs13292136 in the coiled-coil-helix-coiled-coil-helix domain con-
taining 9 [CHCHD9] locus, rs231362 in the KCNQ1 locus,
rs1552224 in the centaurin, delta 2 [CENTD2] locus, rs1531343
in the high mobility group AT-hook 2 [HMGA2] locus, rs7957197
in the 29-59-oligoadenylate synthetase-like [OASL] locus,
rs11634397 in the zinc finger, AN1-type domain 6 [ZFAND6]
locus, and rs8042680 in the protein regulator of cytokinesis 1
[PRC1] locus) [19]. Among them, 2 SNP loci, rs780094 in the
GCKR locus and rs2191349 in the DGKB- TMEM195 locus were
shown to be associated with type 2 diabetes in the Japanese [9,21],
and excluded from the present study.
SNP genotyping was performed by the multiplex-polymerase
chain reaction (PCR)-invader assay, as described previously [22].
Statistical analysis
We performed the Hardy-Weinberg Equilibrium (HWE) test
according to the method described by Nielsen et al [23], and SNPs
Table 1. Clinical characteristics of the participants.
RIKEN case-control study
1
st study
Toyama University study
2
nd study
St. Marianna University Study
3
rd study
Case Control Case Control Case Control
n 1,630 716 724 763 485 646
Sex (M:F) 978:652
b 465:251 451:273
b 359:404 288:197
b 188:458
Age (year)
a 61.5611.6
b 44.369.9 64.9611.1
b 72.569.0 64.2611.5
b 35.0610.3
BMI (kg
2/m
2)
a 23.763.9
b 22.963.1 24.563.9
b 22.763.3 24.964.6
b 21.663.0
HbA1c (%)
a 7.7961.66 N.A. 7.5361.25
b 5.5460.25 7.1460.99
b 5.3660.41
Duration (year)
a 17.368.5 - 13.569.1 - 15.9614.6 -
aData are mean 6 SD. N.A. Not Available.
bP,0.01 vs. Control.
doi:10.1371/journal.pone.0026911.t001
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control groups were excluded from the present analysis. Genotype
distribution differences between the case and control groups were
analyzed by logistic regression analysis, and quantitative traits
analyses were performed by multiple linear regression analysis. To
test the additive model of each SNP with or without adjusting sex
and log transformed body mass index (BMI), the analysis was
performed using StatView software. Combined meta-analysis was
performed by using the Mantel-Haenszel procedure with a fixed
effect model after testing for heterogeneity. Bonferroni’s method
was applied for correcting multiple testing errors. The power of
sample size for the present study to identify the association of
previously reported SNP loci with type 2 diabetes was calculated
using ‘‘CaTS power calculator for genetic studies’’ software
(http://www.sph.umich.edu/csg/abecasis/CaTS/).
Results
Among the 18 SNPs, 3 (rs11708067, rs2877716 in ADCY5 locus,
and rs7957197 in OASL locus) are monoallelic in the Japanese
populations. The genotype distributions of rs13292136 in
CHCHD9 showed significant deviation from the Hardy-Weinberg
equilibrium proportion in the control group (P,0.01, Table S1).
Therefore, we removed these 4 SNPs from the association study.
Then, we examined the association of 14 SNPs within the 13 loci
with type 2 diabetes in 3 independent Japanese case-control
studies (2,839 cases and 2,125 controls). As shown in Table 2, all
13 loci had the same direction of effect (odds ratio .1.0) with
those identified in European studies (P=0.0001, binomial test).
Five SNPs, rs10830963 in the MTNR1B locus, rs2943641 in the
IRS1 locus, rs972283 in the KLF14 locus, rs231362 in the KCNQ1
locus, and rs11634397 in the ZFAND6 locus, had nominal
association with type 2 diabetes in the present Japanese samples
(P,0.05, Table 2 and Table S2), but these associations were not
remained significant after Bonferroni’s correction. When we
combined the present results with those in the previously
performed Japanese GWAS data (4,470 cases vs. 3,071 controls),
11 out of 13 loci showed directionally consistent association with
those in the European populations (P=0.01, binomial test), and
the association of rs2943641 attained statistically significant levels,
whereas rs11634397 in ZFAND6 were no longer associated with
the disease.
We further examined the association of each SNP with glycemic
parameters, HOMA-IR, HOMA-b, and FPG using control
samples of the 1
st and 2
nd study (Table 3). In this analysis, the
reported type 2 diabetes risk alleles for rs1387153 and rs10830963
in the MTNR1B locus had significant association with reduced
beta-cell function or increased FPG as reported previously.
Table 2. Association of 14 SNPs identified in European GWAS with type 2 diabetes in Japanese populations.
SNP Gene Risk Allele
a RAF(case/control) Study 1+2+3 + Previous Japanese GWAS
1
st study 2
nd study 3
rd study p value
c OR (95%CI) p value
c
OR
(95%CI)
rs1387153 MTNR1B T 0.406
/0.387
0.414
/0.410
0.416
/0.382
unadjusted
adjusted
b
0.088
0.55
1.08(0.99–1.17)
1.04 (0.92–1.16)
0.037 1.06 (1.00–1.11)
rs10830963 MTNR1B G 0.426
/0.403
0.444
/0.433
0.438
/0.406
unadjusted
adjusted
b
0.045
0.28
1.09 (1.00–1.19)
1.06 (0.95–1.19)
0.033 1.06 (1.00–1.11)
rs730497 GCK A 0.181
/0.182
0.187
/0.185
0.174
/0.173
unadjusted
adjusted
b
0.97
0.57
1.00 (0.90–1.12)
0.96 (0.84–1.10)
0.84 1.01 (0.94–1.08)
rs2943641 IRS1 C 0.925
/0.918
0.926
/0.901
0.915
/0.903
unadjusted
adjusted
b
0.013
0.0091
1.21 (1.04–1.40)
1.30 (1.07–1.58)
0.0034 1.15 (1.05–1.26)
rs340874 PROX1 G 0.389
/0.386
0.397
/0.363
0.411
/0.382
unadjusted
adjusted
b
0.059
0.041
1.09 (0.997–1.18)
1.12 (1.00–1.25)
0.19 1.04 (0.98–1.09)
rs243021 BCL11A T 0.695
/0.700
0.689
/0.692
0.690
/0.673
unadjusted
adjusted
b
0.90
0.98
1.01 (0.92–1.10)
0.998 (0.89–1.12)
0.39 0.98 (0.92–1.03)
rs4457053 ZBED3 G 0.024
/0.016
0.021
/0.023
0.023
/0.020
unadjusted
adjusted
b
0.27
0.75
1.18 (0.88–1.58)
1.06 (0.73–1.55)
0.77 0.97 (0.81–1.17)
rs972283 KLF14 G 0.760
/0.720
0.750
/0.723
0.735
/0.735
unadjusted
adjusted
b
0.0054
0.052
1.14 (1.04–1.26)
1.13 (0.999–1.27)
0.017 1.07 (1.01–1.14)
rs896854 TP53INP1 A 0.307
/0.317
0.310
/0.295
0.321
/0.308
unadjusted
adjusted
b
0.70
0.52
1.02 (0.93–1.11)
1.04 (0.92–1.17)
0.43 1.02 (0.97–1.08)
rs231362 KCNQ1 C 0.902
/0.899
0.921
/0.910
0.925
/0.890
unadjusted
adjusted
b
0.025
0.10
1.18 (1.02–1.36)
1.17 (0.97–1.41)
0.009 1.12 (1.03–1.23)
rs1552224 CENTD2 T 0.965
/0.966
0.964
/0.955
0.971
/0.963
unadjusted
adjusted
b
0.22
0.40
1.15 (0.92–1.43)
1.13 (0.85–1.49)
0.058 1.14 (0.996–1.31)
rs1531343 HMGA2 C 0.137
/0.124
0.124
/0.141
0.151
/0.127
unadjusted
adjusted
b
0.39
0.61
1.06 (0.93–1.19)
0.96 (0.82–1.12)
0.11 1.06 (0.99–1.15)
rs11634397 ZFAND6 G 0.129
/0.105
0.111
/0.114
0.123
/0.105
unadjusted
adjusted
b
0.043
0.082
1.14 (1.00–1.30)
1.16 (0.98–1.38)
0.35 1.04 (0.96–1.13)
rs8042680 PRC1 A 0.998
/0.995
0.999
/0.999
0.997
/0.999
unadjusted
adjusted
b
0.33
0.13
1.49 (0.64–3.48)
2.50 (0.76–8.18)
0.28 1.40 (0.74–2.64)
arisk allele reported in the previous reports.
badjusting sex, age and log-transformed BMI.
cNominal P values are presented.
doi:10.1371/journal.pone.0026911.t002
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significantly associated with increased FPG.
Discussion
In the present study, we examined 14 SNPs within 13
susceptibility loci for type 2 diabetes in 3 independent Japanese
samples, and identified that rs2943641 near IRS1 was significantly
associated with type 2 diabetes when we combined the present
data with those in the previous Japanese GWAS data.
GWAS conducted in European and East Asian populations
have revealed multiple risk-associated loci for type 2 diabetes, and
some of them have been confirmed and shown to be common
across different ethnic groups [24].
In this study, we identified a significant association of rs2943641
near IRS1 locus, with type 2 diabetes in the Japanese population.
The risk allele (C) was consistent with that of a previous study in
European populations [13], suggesting this locus is a common
susceptibility locus for type 2 diabetes across different ethnic
groups. We further identified nominal associations of 3 SNPs with
type 2 diabetes in the Japanese population. The risk alleles of these
SNPs were consistent with those identified in a European study,
suggesting that these 3 SNPs were also good candidates for
association with type 2 diabetes in the Japanese. Moreover, most
of 13 loci showed directionally consistent association with the
previous report; therefore, there are several possibilities for the
lack of replication. Regarding ethnic differences, there are
moderate heterogeneity in effect size for 4 loci, rs730497,
rs340874, rs243021 and rs11634397 (50,I
2,80), whereas no
heterogeneity in effect size (odds ratio) was observed on the
remaining loci (data not shown). We could not observe remarkable
differences in LD structures around each locus between Japanese
and European populations (Figure S1). Therefore a lack of
replication for most loci might be explained by the insufficient
power of the present study (5–63% for the present 3 studies, 5–
95% for the 3 studies + previous GWAS samples if we set a cut-off
value at P=0.05 and the prevalence of type 2 diabetes is assumed
to be 10%, Table S3).
The analyses of quantitative traits related to glucose metabolism
revealed that SNPs in the MTNR1B locus were significantly
associated with decreased beta-cell function or increased FPG as
reported previously (Table 3). In this analysis, we also found that
HMGA2 locus was significantly associated with increased FPG in
these samples, suggesting that SNPs in the MTNR1B or the
HMGA2 loci confer susceptibility to type 2 diabetes in Japanese
populations. In addition, risk allele of rs2943641 near IRS1 tended
Table 3. Association of the 14 SNPs with quantitative traits related to glucose metabolism in the 1st and 2nd study controls.
SNP Gene Risk allele
a HOMA-IR
b HOMA-ß
b FPG
c
Effect (SE) p Effect (SE) p value Effect (SE) p
rs1387153 MTNR1B T unadjusted
adjusted
d
20.008 (0.038)
20.022 (0.035)
0.84
0.53
26.942 (2.092)
27.071 (1.967)
0.0009
0.0003
1.471 (0.443)
1.308 (0.422)
0.0009
0.002
rs10830963 MTNR1B G unadjusted
adjusted
d
20.051 (0.038)
20.044 (0.034)
0.18
0.20
26.957 (2.064)
26.316 (1.944)
0.0008
0.0012
1.445 (0.441)
1.381 (0.420)
0.0011
0.001
rs730497 GCK A unadjusted
adjusted
d
20.024 (0.046)
20.027 (0.042)
0.60
0.53
22.020 (2.544)
21.897 (2.386)
0.43
0.43
0.467 (0.552)
0.366 (0.524)
0.40
0.49
rs2943641 IRS1 C unadjusted
adjusted
d
0.105 (0.061)
0.136 (0.055)
0.084
0.014
4.141 (3.367)
4.760 (3.149)
0.22
0.13
0.180 (0.749)
0.311 (0.711)
0.81
0.66
rs340874 PROX1 G unadjusted
adjusted
d
20.067 (0.038)
20.087 (0.035)
0.078
0.013
23.193 (2.089)
22.932 (1.960)
0.13
0.14
0.640 (0.446)
0.416 (0.425)
0.15
0.33
rs243021 BCL11A T unadjusted
adjusted
d
0.014 (0.041)
0.012 (0.037)
0.73
0.75
20.490 (2.238)
0.208 (2.106)
0.83
0.92
0.639 (0.472)
0.515 (0.450)
0.18
0.25
rs4457053 ZBED3 G unadjusted
adjusted
d
20.074 (0.119)
20.081 (0.107)
0.53
0.45
22.313 (6.621)
22.729 (6.181)
0.73
0.66
0.691 (1.543)
0.902 (1.465)
0.65
0.54
rs972283 KLF14 G unadjusted
adjusted
d
20.030 (0.042)
20.047 (0.037)
0.47
0.21
1.269 (2.287)
0.492 (2.140)
0.58
0.82
20.173 (0.484)
20.290 (0.460)
0.72
0.53
rs896854 TP53INP1 A unadjusted
adjusted
d
0.003 (0.041)
20.007 (0.37)
0.95
0.84
0.940 (2.242)
0.558 (2.104)
0.68
0.79
20.422 (0.474)
20.314 (0.450)
0.37
0.49
rs231362 KCNQ1 C unadjusted
adjusted
20.057 (0.064)
20.053 (0.058)
0.37
0.36
20.092 (3.517)
20.469 (3.300)
0.98
0.89
20.305 (0.737)
20.184 (0.701)
0.68
0.79
rs1552224 CENTD2 T unadjusted
adjusted
d
20.031 (0.091)
0.004 (0.082)
0.73
0.96
22.219 (5.035)
20.596 (4.708)
0.66
0.90
22.915 (1.103)
22.762 (1.047)
0.0083
0.0085
rs1531343 HMGA2 C unadjusted
adjusted
d
0.101 (0.052)
0.101 (0.047)
0.053
0.032
1.855 (2.868)
1.336 (2.706)
0.52
0.62
1.840 (0.612)
1.780 (0.585)
0.0027
0.0024
rs11634397 ZFAND6 G unadjusted
adjusted
d
20.061 (0.059)
20.050 (0.054)
0.30
0.35
0.895 (3.283)
0.984 (3.076)
0.79
0.75
0.390 (0.709)
0.409 (0.674)
0.58
0.54
rs8042680 PRC1 A unadjusted
adjusted
d
20.586 (0.385)
20.733 (0.347)
0.13
0.035
2.873 (21.24)
27.444 (19.87)
0.89
0.71
22.917 (3.703)
22.407 (3.515)
0.43
0.49
Results of linear regression analyses.
arisk allele for type 2 diabetes reported in the previous reports.
bn=925,
cn=1,378.
dadjusting sex , age and log-transformed BMI.
doi:10.1371/journal.pone.0026911.t003
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previously, further confirming the contribution of this locus with
susceptibility to type 2 diabetes in the Japanese.
Limitations
The present study has some limitations. First, the present
sample size is not sufficiently large to detect true associations for
some loci as described above. Second, control subjects in the 1
st
and 3
rd study are younger than type 2 diabetes patients. Although,
results were not affected by adjusting age, these limitations may
increase the possibility for type 2 error.
In conclusion, these results indicate that the IRS1 locus is
considered common locus involved in susceptibility to type 2
diabetes across different ethnic groups. Three loci—MTNR1B,
KLF14, and KCNQ1 (independent locus from a locus identified in
Japanese GWAS)— may also have some effects. Further studies
are required to elucidate the association of these as well as other
loci with susceptibility to type 2 diabetes, and to understand the
biological significance of these genes and their polymorphisms.
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